Work

Drug retention rates of second biologic agents after switching from tumor necrosis factor inhibitors for rheumatoid arthritis in Japanese patients on low-dose methotrexate or without methotrexate

Year: 2014

Type: article

Study design: Observational Study

Source: Modern Rheumatology

DOI: 10.3109/14397595.2014.953668

Authors: Tomonori Kobayakawa, Toshihisa Kojima, Nobunori Takahashi, Masatoshi Hayashi, Yuichiro Yabe, Atsushi Kaneko, Tomone Shioura, Kiwamu Saito, Yuji Hirano, Yasuhide Kanayama, Hiroyuki Miyake, Nobuyuki Asai, Koji Funahashi, Shinya Hirabara, Masahiro Hanabayashi, Shuji Asai, Naoki Ishiguro

Institutions: Nagoya University Hospital, Nagano Red Cross Hospital, Japan Community Healthcare Organization, Nagoya Medical Center, Toyohashi Municipal Hospital, Toyota Kosei Hospital, Ichinomiya Municipal City Hospital

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Japan Society for the Promotion of Science

Awards: Inhibitory effects of combination therapy of denosumab, anti-RANKL antibody, and biological DMARD on bone and cartilage destruction in patients with rheumatoid arthritis, The development of new measurement methods in radiographic image.

OpenAlex ID: W2054972003

FWCI: 1.854

Cites: 37

Cited by: 19

Related to: 10